Back to Journals » Drug Design, Development and Therapy » Volume 12

Review

Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2– advanced breast cancer

       
Total article views   HTML views PDF downloads Totals
30,626 Dovepress* 19,004+ 2,767 21,771
PubMed Central* 11,622 1,978 13,600
Totals 30,626 4,745 35,371
*Since 16 February 2018
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 0 1 6

View citations on PubMed Central and Google Scholar